Literature DB >> 2473047

Effect of inhibitors of arachidonic acid metabolism on corneal neovascularization in the rat.

W L Haynes1, A D Proia, G K Klintworth.   

Abstract

We used computerized image analysis to evaluate quantitatively the ability of topically applied corticosteroids (dexamethasone sodium phosphate, prednisolone acetate), cyclooxygenase inhibitors (flurbiprofen, indomethacin, ketorolac), lipoxygenase inhibitors (REV 5901, esculetin, quercetin), and dual cyclooxygenase/lipoxygenase inhibitors (BW 755C, BW A540C) to reduce corneal neovascularization in the rat induced by silver/potassium nitrate cauterization. Significant decreases in the neovascular response were found with corticosteroids and cyclooxygenase inhibitors. A complete dose-response curve was performed for a representative compound from each class. Dexamethasone was found to be superior to flurbiprofen in its ability to reduce neovascularization in this model, while no significant inhibition was noted with either REV 5901 or BW 755C, even at high doses. We conclude that the corneal angiogenic response in this model can be reduced by inhibition of cyclooxygenase as well as by other mechanisms that are steroid-dependent but are, as yet, poorly defined.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2473047

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  15 in total

Review 1.  Angiogenesis and angiogenesis inhibitors in paediatric diseases.

Authors:  L Schweigerer; T Fotsis
Journal:  Eur J Pediatr       Date:  1992-07       Impact factor: 3.183

2.  Laser photocoagulation for corneal stromal vascularization.

Authors:  V S Nirankari
Journal:  Trans Am Ophthalmol Soc       Date:  1992

3.  Inhibition of experimental corneal neovascularisation by bevacizumab (Avastin).

Authors:  Roberta P A Manzano; Gholam A Peyman; Palwasha Khan; Petros E Carvounis; Muhamet Kivilcim; Min Ren; Jonathan C Lake; Patricia Chévez-Barrios
Journal:  Br J Ophthalmol       Date:  2006-12-19       Impact factor: 4.638

4.  Selective activation of the prostaglandin E2 circuit in chronic injury-induced pathologic angiogenesis.

Authors:  Elvira L Liclican; Van Nguyen; Aaron B Sullivan; Karsten Gronert
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-07-07       Impact factor: 4.799

Review 5.  Quercetin and the ocular surface: What we know and where we are going.

Authors:  Tina B McKay; Dimitrios Karamichos
Journal:  Exp Biol Med (Maywood)       Date:  2017-01-05

6.  Localization of angiotensin converting enzyme in rabbit cornea and its role in controlling corneal angiogenesis in vivo.

Authors:  Ajay Sharma; Daniel I Bettis; John W Cowden; Rajiv R Mohan
Journal:  Mol Vis       Date:  2010-04-23       Impact factor: 2.367

Review 7.  Current and Upcoming Therapies for Ocular Surface Chemical Injuries.

Authors:  Alireza Baradaran-Rafii; Medi Eslani; Zeeshan Haq; Ebrahim Shirzadeh; Michael J Huvard; Ali R Djalilian
Journal:  Ocul Surf       Date:  2016-09-17       Impact factor: 5.033

Review 8.  Angiogenesis and rheumatoid arthritis: pathogenic and therapeutic implications.

Authors:  P R Colville-Nash; D L Scott
Journal:  Ann Rheum Dis       Date:  1992-07       Impact factor: 19.103

9.  Anti-VEGF monoclonal antibody-induced regression of corneal neovascularization and inflammation in a rabbit model of herpetic stromal keratitis.

Authors:  Mario Saravia; Gustavo Zapata; Paula Ferraiolo; Lourdes Racca; Alejandro Berra
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-08-05       Impact factor: 3.117

10.  The NSAID sulindac reverses rectal adenomas in colectomized patients with familial adenomatous polyposis: clinical results of a dose-finding study on rectal sulindac administration.

Authors:  G Winde; H G Gumbinger; H Osswald; F Kemper; H Bünte
Journal:  Int J Colorectal Dis       Date:  1993-03       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.